Frontlight ResearchEarly access
Neuroendocrine tumours trials in Switzerland
1 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking people61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
- Where
- Basel
- Age
- 18 years and over
- People
- 27
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT06455358